Animal cancer treatment unit opens in Cambridge
MONDAY 13 OCTOBER 2008
A new facility for treating animals with cancer has opened at the University of Cambridge's Queen's Veterinary School Hospital.
The new extension to the Cancer Therapy Unit will work in collaboration with the Cancer Research UK Cambridge Research Institute to study cancer in pet animals - information that could also benefit human cancer patients.
Only three centres currently offer radiotherapy to animals in England, and the Cambridge facility - which first opened in 1991 - is the only one in Europe that can treat horses and other large animals.
The new linear accelerator will enable us to continue to provide the very best treatment and clinical care.
- Dr Jane Dobson, Cancer Therapy Unit
It now houses a new linear accelerator which is identical to those used in the treatment of human cancer patients and which treats over 20 animals per week.
Dr Jane Dobson, reader in veterinary oncology, commented: "The new linear accelerator will enable us to continue to provide the very best treatment and clinical care for our patients."
The linear accelerator works by directing radiation at the tumours which cannot be treated with surgery alone.
As many as one in four dogs and one in eight cats are affected by cancer at some stage during their lifetime and cancer is actually the leading cause of death in dogs.
However, the centre receives no government funding and is therefore reliant on donations to cover the costs of building work, lifesaving equipment and ongoing research.
Cancer Research UK welcomes new NHS drugs deal
Information from brain tumour sacs may help to guide treatment
Protein forces ovarian cancer cells to eat themselves
Raising alcohol taxes shown to reduce deaths
Scientists use new approach to hunt down cancer-causing genes
Family history may have role in brain cancer
Large waist nearly doubles risk of premature death
New radar imaging system could improve breast screening
Report calls for under-18 sunbed ban
Drugs designed to block blood vessel growth may aid anti-cancer drug delivery
